Health Highlights: March 28, 2022

Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more
Second COVID-19 vaccine boosters to be offered to Americans over 50. Optional second boosters of the Pfizer or Moderna vaccines could be authorized by the U.S. Food and Drug Administration as early as this week. But debate rages over the timing and effectiveness of such a move. Read more
Owners can play big role in dogs' problem behaviors. Nearly 1 in 3 pet dogs suffer from ADHD-like repetitive behaviors, and researchers now suspect that an animal's home life could be the cause. Read more
Hospitalization extremely rare for the vaccinated or those with prior COVID infection. A study of more than 100,000 American patients found their odds of winding up in the hospital following a 'breakthrough' infection was practically nil. Read more
Related Posts
Los estimulantes como Ritalin podrían ser una droga de entrada para los estudiantes universitarios
VIERNES, 8 de octubre de 2021 (HealthDay News) -- En algún momento se pensó que...
¿Tiene diabetes tipo 2? Cambiar las bebidas diarias podría añadirle años a su vida
JUEVES, 20 de abril de 2023 (HealthDay News) -- Suelte ese refresco con azúcar....
Source of Pathogen Infection in Four Hospitalized Patients Identified
TUESDAY, March 14, 2023 (HealthDay News) -- Hospital tap water and ice can...
La FDA comenzará a regular miles de pruebas de laboratorio
LUNES, 2 de octubre de 2023 (HealthDay News) - Frente a crecientes informes de...